Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Subset of breast cancer patients found to benefit from neratinib in latest trial

Dr John W. Park - University of California San Francisco, San Francisco, USA
Subset of breast cancer patients found to benefit from neratinib in latest trial ( Dr John W. Park - University of California San Francisco, San Francisco, USA )
1 May 2014

"Exciting" implications of bemacyclib study in the treatment of breast cancer

Dr Amita Patnaik - South Texas Accelerated Research Therapeutics, San Antonio, USA
"Exciting" implications of bemacyclib study in the treatment of breast cancer ( Dr Amita Patnaik - South Texas Accelerated Research Therapeutics, San Antonio, USA )
1 May 2014

Immunotherapy in melanoma

Dr Adil I. Daud - University of California San Francisco School of Medicine, San Francisco, USA
Immunotherapy in melanoma ( Dr Adil I. Daud - University of California San Francisco School of Medicine, San Francisco, USA )
1 May 2014

Impact of the liver environment upon the efficacy of induction therapy

Dr Frederic Bibeau - Institut regional du Cancer, Montpellier, France
Impact of the liver environment upon the efficacy of induction therapy ( Dr Frederic Bibeau - Institut regional du Cancer, Montpellier, France )
1 May 2014

Study identifies new strategy to overcome breast cancer resistance to HER2-targeted therapies

Dr Joan Garrett - Vanderbilt University Medical Center, Nashville, USA
Study identifies new strategy to overcome breast cancer resistance to HER2-targeted therapies ( Dr Joan Garrett - Vanderbilt University Medical Center, Nashville, USA )
1 May 2014

Promising advances in the treatment of lung cancer using MK-3475 as an immune checkpoint inhibitor

Dr Leena Gandhi - Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA
Promising advances in the treatment of lung cancer using MK-3475 as an immune checkpoint inhibitor ( Dr Leena Gandhi - Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA )
1 May 2014

Effective use of ibrutinib in the treatment of ABC lymphoma tumours

Dr Louis Staudt - National Cancer Institute, Bethesda, USA
Effective use of ibrutinib in the treatment of ABC lymphoma tumours ( Dr Louis Staudt - National Cancer Institute, Bethesda, USA )
1 May 2014

Biomarker identifies melanoma patients who may respond to immunotherapy MK-3475

Dr Adil I. Daud - University of California San Francisco School of Medicine, San Francisco, USA
Biomarker identifies melanoma patients who may respond to immunotherapy MK-3475 ( Dr Adil I. Daud - University of California San Francisco School of Medicine, San Francisco, USA )
1 May 2014

Benefits found for lung cancer patients with high levels of PD-L1 with MK-3475 treatment

Dr Leena Gandhi - Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA
Benefits found for lung cancer patients with high levels of PD-L1 with MK-3475 treatment ( Dr Leena Gandhi - Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA )
1 May 2014

Role of genomics in assessing risk, especially in ovarian cancer

Dr Thomas Sellers - Moffitt Cancer Center, Tampa, USA
Role of genomics in assessing risk, especially in ovarian cancer ( Dr Thomas Sellers - Moffitt Cancer Center, Tampa, USA )
1 May 2014

The relationship between obesity and cancer, and other dietary factors

Dr Walter C. Willett - Harvard School of Public Health, Boston, USA
The relationship between obesity and cancer, and other dietary factors ( Dr Walter C. Willett - Harvard School of Public Health, Boston, USA )
25 Apr 2014

New antibody-drug conjugate shows early promise against all forms of melanoma

Dr Jeffrey Infante - Tennessee Oncology, Nashville, USA
New antibody-drug conjugate shows early promise against all forms of melanoma ( Dr Jeffrey Infante - Tennessee Oncology, Nashville, USA )
16 Apr 2014